TY  - GEN
AU  - Pishvaian,Michael J
AU  - Slack,Rebecca
AU  - Koh,Eunice Y
AU  - Beumer,Jan H
AU  - Hartley,Marion L
AU  - Cotarla,Ion
AU  - Deeken,John
AU  - He,Aiwu Ruth
AU  - Hwang,Jimmy
AU  - Malik,Shakun
AU  - Firozvi,Kashif
AU  - Liu,Minetta
AU  - Elston,Beth
AU  - Strychor,Sandy
AU  - Egorin,Merrill J
AU  - Marshall,John L
TI  - A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy
SN  - 1432-0843
PY  - 2013///0124
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Benzamides
KW  - Chemotherapy, Adjuvant
KW  - Cohort Studies
KW  - Disease Progression
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Imatinib Mesylate
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Neutropenia
KW  - chemically induced
KW  - Paclitaxel
KW  - Piperazines
KW  - Pyrimidines
KW  - Radiotherapy, Adjuvant
KW  - Severity of Illness Index
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-012-1969-9
ER  -